...
首页> 外文期刊>European review for medical and pharmacological sciences. >Human milk antibiotic residue levels and their relationship with delivery mode, maternal antibiotic use and maternal dietary habits
【24h】

Human milk antibiotic residue levels and their relationship with delivery mode, maternal antibiotic use and maternal dietary habits

机译:人乳抗生素残留水平及其与分娩方式,母体抗生素使用和母体饮食习惯的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: It is important to identify undesirable toxins and metabolites present in human milk that may be passed on to nursing infants. Such residues may derive from the antibiotics that are widely used to treat infectious diseases in both humans and food-producing animals. To the best of our knowledge, there are no reports in the literature on human milk antibiotic residue levels. PATIENT AND METHODS: As a part of the Human Milk Artificial Pollutants (HUMAP) study, we aimed to evaluate human milk antibiotic residues among mothers with 7 to 90-day-old babies. Pregnant women who had received antibiotic treatment during pregnancy were excluded. The use of antibiotic prophylaxis with cefazoline sodium during labor was noted among the study subjects. Human milk antibiotic residues were evaluated with the InfiniPlex for Milk Array (Randox Laboratories, London, United Kingdom), a semi-automated system with a multi-array biochip designed to detect antibiotic residues and toxins. RESULTS: The HUMAP study included 83 mothers, ranging in age from 17 to 41 years (mean 29.7 ± 6.2 years). Of these, 59% received cefazoline sodium shortly after birth, while 41% did not receive any antibiotics during the pregnancy, delivery or lactational periods. Testing revealed that 71/83 (85.5%) human milk samples were positive for beta-lactams and 12 (14.5%) samples were positive for quinolones. There was no difference in maternal age, gestational week, delivery type, sampling time, maternal dietary habits between the mothers with quinolones or beta-lactam residues in their milk and those without (p 0.05 for both). Beta-lactam and quinolone residues were detected in 85.7% and 23.5%, respectively, of the human milk samples of mothers who did not receive antibiotics at birth and/or during the first seven days after birth. CONCLUSIONS: We found that the majority of human milk samples included beta-lactams or quinolones, even though the mothers did not receive these antibiotics during pregnancy and lactation. Antibiotic residues in human milk may affect early maintenance of the intestinal microbiota. Previous studies have shown that antimicrobials in food might increase the risks of allergies and could lead to the development of antibiotic-resistant bacterial strains. Effective policies on food safety and appropriate antibiotic use during pregnancy and lactation are needed.
机译:目的:确定母乳中可能会传递给哺乳婴儿的不良毒素和代谢产物非常重要。此类残留物可能源自广泛用于治疗人类和食品生产动物的传染病的抗生素。据我们所知,文献中没有关于母乳中抗生素残留水平的报道。患者和方法:作为人乳人工污染物(HUMAP)研究的一部分,我们旨在评估7至90天大婴儿的母亲中的人乳抗生素残留。排除了在怀孕期间接受抗生素治疗的孕妇。研究对象中注意到在分娩过程中使用头孢唑啉钠预防抗生素。使用InfiniPlex牛奶阵列(Randox实验室,伦敦,英国)评估了人乳中的抗生素残留,这是一个半自动化系统,具有用于检测抗生素残留和毒素的多阵列生物芯片。结果:HUMAP研究包括83位母亲,年龄从17岁到41岁(平均29.7±6.2岁)。其中59%的人在出生后不久就接受了头孢唑啉钠,而41%的人在怀孕,分娩或哺乳期未接受任何抗生素。测试显示,71/83(85.5%)的人乳样品中β-内酰胺呈阳性,而12(14.5%)的样品中喹诺酮呈阳性。牛奶中有喹诺酮或β-内酰胺残留的母亲与无牛奶的母亲的孕产妇年龄,孕周,分娩类型,取样时间,母亲的饮食习惯没有差异(两者均p> 0.05)。在出生时和/或出生后前7天未接受抗生素治疗的母亲的人乳样品中,分别检出了85.7%和23.5%的β-内酰胺和喹诺酮残留。结论:我们发现,即使母亲在怀孕和哺乳期间未接受这些抗生素,大多数人乳样品中也包含β-内酰胺或喹诺酮类药物。人乳中的抗生素残留可能会影响肠道菌群的早期维持。先前的研究表明,食品中的抗菌剂可能会增加过敏的风险,并可能导致产生耐药性细菌菌株。需要制定有效的食品安全政策,并在怀孕和哺乳期间适当使用抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号